New Challenges in the Management of Heart Failure - Meet the Experts

New Challenges in the Management of Heart Failure - Meet the Experts

Tackling practical issues in the management of the heart failure patient

Advances in Heart Failure Management - Tackling Cardio-Renal and Metabolic Disease


This webinar is part of a 2-day integral programme in Heart Failure. Please use the links provided to view both day’s agenda and to register for each session.

Thursday 5th November 2020

WEBINAR II - Advances in Heart Failure Management - Tackling Cardio-Renal and Metabolic Disease

Chair: Giuseppe Rosano

12:00 - 12:10 Welcome and introductionJuan Carlos Kaski
12:10 - 12:35 Diabetes and HF - Clinical impact of new oral antidiabetic agents.Ramzi Ajjan
12:35 - 13:00 Iron deficiency, frailty, clinical outcomes and management.Theresa McDonagh
13:00 - 13:25 How to manage cardio-renal issues in HF.Debasish Banerjee
13:25 - 14:00 MDT Case Presentations - Managing HF in patients with diabetes and CKDALL
Chair: Theresa McDonagh
Panel members: Ramzi Ajjan, Debasish Banerjee, Robin Ray, Giuseppe Rosano


Professor Juan Carlos Kaski
Programme Co-Director
Professor Kaski is Professor of Cardiovascular Science, St Gorge’s, University of London, the immediate past-Director of the Cardiovascular and Cell Sciences Research Institute at St George’s, University of London. He is Doctor Honoris Causa of several universities worldwide, a Past-President of the International Society of Cardiovascular Pharmacotherapy, Chairman -elect, European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy, and Fellow of over 30 scientific societies worldwide. Professor Kaski is Editor-in-Chief, European Cardiology Review Journal, Deputy Editor, European Heart Journal, Associate Editor, Cardiovascular Drugs and Therapy and editorial board member of JACC, the European Heart Journal and over 20 other scientific journals. Prof Kaski has wide expertise in the diagnosis and treatment of INOCA conditions and his research areas include inflammatory and immunological mechanisms of atherosclerosis, microvascular and vasospastic angina, biomarkers of cardiovascular risk and management of angina pectoris. He has authored over 500 scientific papers on these topics in peer review journals.


Professor Giuseppe Rosano
Programme Co-Director and Chair
Prof Rosano is a Consultant Cardiologist and Professor of Cardiology, Director of the MSc in Heart Failure at St George’s, University of London, and Scientific Director of the Nutramed programme at the IRCCS San Raffaele, in Rome.

He serves as an expert in cardiovascular medicine for the European Assessment Office of the Italian Drug Agency and is a core member of the Cardiovascular Working Party of the European Medicines Agency.

Prof Rosano is a board member and Treasurer of the Heart Failure Association (HFA), and is chairman of the HFA's education committee and the HFA Study Group on Diabetes and Hypertension.


Professor Ramzi Ajjan
Prof Ajjan is a Professor of Metabolic Medicine and an Honorary Consultant in Diabetes and Endocrinology at Leeds University and Leeds Teaching Hospitals Trust. He obtained his PhD from the University of Sheffield and completed his clinical training in Diabetes and Endocrinology at Leeds Teaching Hospitals. He runs a programme of basic, translational and clinical research studies with the collective aim of reducing vascular complications and improving quality of life in individuals with diabetes. His clinical studies have focussed on optimising glycaemic control by reducing high glucose levels while avoiding hypoglycaemia and keeping glucose variability to a minimum. His translational work aims to uncover novel therapeutic targets to reduce the prothrombotic environment in diabetes, a key abnormality in this condition. He has over 150 publications including original articles, reviews and book chapters. His clinical practice concentrates on young adults with diabetes and older individuals at high risk of vascular disease.

He is local R&D lead for Diabetes/Endocrinology and regional clinical research network co-lead for diabetes, endocrine and metabolic conditions. He is deputy Chair of the Clinical Study Group 2 at Diabetes UK, Associate Editor of Diabetes and Vascular Disease Research and member of the editorial board of International Journal of Molecular Sciences.


Professor Theresa McDonagh
Prof Theresa McDonagh is a Consultant Cardiologist at King's College London. Her research interests are in clinical heart failure; in particular, the epidemiology of heart failure and left ventricular dysfunction and the role of biomarkers. Professor McDonagh is currently Chair of the Clinical Section of the Heart Failure Association of ESC and Clinical Lead for the National Heart Failure Audit.


Professor Debasish Banerjee
Prof Debasish Banerjee is a consultant nephrologist with a special interest in cardiovascular complications of chronic kidney disease including heart failure, sudden cardiac death and cardiac workup before kidney transplantation.

He serves as the Clinical Sub dean for St George’s Hospital and previously the Higher Education Academic Director for the international MBBS program at St George’s, University of London.

He has recently been appointed as the Chair of the Training and Education Committee of the UK Renal Association.

As a member of the European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacotherapy, and following his establishment of a unique kidney failure - heart failure clinic at St George’s, he has helped with strategies for managing CKD patients with cardiovascular disease. As part of the Association of British Clinical Diabetologists (ABCD) Renal Association Clinical Study Group, he has assisted in the formulation of national guidelines for the management of CKD patients with diabetes, hypertension and heart disease.

His research interest includes cardiac and vascular changes in chronic kidney disease with impact of vitamin D and kidney transplantation. He has received several research grants including those British Heart Foundation, National Institute of Healthcare Research, British Renal Society, Guys & St. Thomas’ Charity and St. Georges’ Charity. He is the centre Director for the International Society of Nephrology Renal Sister Centre programme fostering collaboration in research and education with international other centres.


Dr Robin Ray
Panel member
Dr Robin Ray is a Consultant Cardiologist at St George’s University Hospitals NHS Foundation Trust in London and has an interest in Heart Failure and cardiac imaging. He has also been the Head of Education from September 2015.

Dr Ray is passionate about education and actively teaches at an undergraduate and postgraduate level. He was appointed as a member on the Educational committee on the European Heart Failure association in 2017 and became a fellow in 2020. He is also co-director of the MSc programme in Heart failure at St George's University. Dr Ray was one of three consultants who developed and implemented the first national Acute Heart Failure Unit in the UK which opened in 2016. This provides specialist nursing, therapist and cardiology care to patients with heart failure. His clinical interests are General Cardiology, Heart Failure and Cardiac Imaging (Cardiac Magnetic Resonance Imaging and Echocardiography). He has also introduced person-centred care for patients with heart failure to the heart failure unit at St George’s to improve patient experience and provide a centre of excellence to train heart failure nurses and fellows.

Dr Ray has ongoing research interests in acute heart failure and iron deficiency anaemia and is the principal investigator on a number of acute heart failure trials.


This online clinical academic event will focus on recent advances in the management of heart failure. The event consists of two online sessions (webinar format) on consecutive days and approximately 2 hours in duration each. As the focus of the programme is on practical management of heart failure, the webinar sessions will be based on exemplary clinical cases and guideline recommendations to provide the attendees with up to date expert opinion on the different aspects of pharmacological treatment of heart failure.

All Faculty members are experts of international calibre with extensive clinical and research networks worldwide. Most of them have contributed to the development of national and international management guidelines.

  • To gain insight into the most recent developments in the pathophysiology of different forms of heart failure, including HFpEF and HFrEF.
  • To briefly discuss non-cardiac treatments affecting heart function i.e. oncological treatments.
  • To discuss current international management guidelines and their application to specific cases.
  • To gain insight into the management of heart failure patients affected by different co-morbidities such as diabetes and chronic kidney disease.
  • To present and discuss the management of iron deficiency and frailty in heart failure.

The webinar is aimed at cardiac consultants, diabetologists, vascular surgeons, renal physicians, general practitioners with an interest in cardiovascular disease, specialist nurses and other health professionals involved in heart failure, cardiovascular risk assessment and management, and trainees in all of the above areas.

  • Cubbon RM, Adams B, Rajwani A, et al. Diabetes mellitus is associated with adverse prognosis in chronic heart failure of ischaemic and non-ischaemic aetiology. Diab Vasc Dis Res. 2013;10(4):330-336.
  • Lehrke M, Marx N. Diabetes Mellitus and Heart Failure. Am J Cardiol. 2017;120(1S):S37-S47.
  • McDonagh T, Damy T, Doehner W, et al. Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practice. Eur J Heart Fail. 2018;20(12):1664-1672.
  • Jenkins R, Mandarano L, Gugathas S, Kaski JC, Anderson L, Banerjee D. Impaired renal function affects clinical outcomes and management of patients with heart failure. ESC Heart Fail. 2017;4(4):576-584
  • Nguyen M, Rumjaun S, Lowe-Jones R, et al. Management and outcomes of heart failure patients with CKD: experience from an inter-disciplinary clinic [published online ahead of print, 2020 Jul 11]. ESC Heart Fail. 2020;10.1002

Go to WEBINAR I - Heart Failure in 2020 - Where are we now and ‘Quo Vadis’?

This programme has been devised exclusively and independently by the meeting’s scientific committee and has been endorsed by St George’s University of London and ISCP. The industry has provided an unrestricted educational grant to cover organisational costs and has had no input into the agenda or content of this educational activity.